[An earlier version of this post misinterpreted Pfizer CEO Albert Bourla’s English. It seemed like he was sowing doubt about the safety of his own COVID shots. Instead, he was alluding to a “safety profile” issue regarding his competitor’s current shingles vaccination (Shingrix is made by Pfizer competitor GSK and it has 90% market share), which he claimed can be solved with mRNA.]